Cyred Eq
Product Images NDC 53002-2722

5 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyred Eq (NDC 53002-2722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Deso Ethi Str)

Chemical Structure (Deso Ethi Str)
Chemical structures of desogestrel and ethinyl estradiol are shown. The diagrams depict the molecular formulas with labeled hydroxyl groups and characteristic bonds for each compound, common active ingredients in hormonal therapies.*
FDA Label Image

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)
Bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) for four categories: ever-users (smokers), ever-users (non-smokers), controls (smokers), and controls (non-smokers). Mortality rates increase with age, with highest rates observed in ever-users who smoke, especially in the 45+ age group.*
FDA Label Image

Figure 2: Risk Of Breast Cancer With Combined Oral Contraceptive Use (Deso Ethi Fig2)

Figure 2: Risk Of Breast Cancer With Combined Oral Contraceptive Use (Deso Ethi Fig2)
Cycle tracking card for Cyred EQ oral contraceptive tablets by RPK Pharmaceuticals, Inc. The card is arranged in four horizontal rows labeled Week 1 through Week 4, each showing circles for days Sunday through Saturday with directional arrows indicating the order of daily use. The Week 4 row circles are green, while weeks 1 to 3 are white to off-white. The label notes the active ingredients as Desogestrel and Ethinyl Estradiol tablets USP 0.15 mg/0.03 mg.*
FDA Label Image

Figure 3 (Deso Ethi Fig3)

Figure 3 (Deso Ethi Fig3)
A weekly tablet intake calendar for Cyred EQ (Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg). The diagram organizes four weeks in rows, each showing circles representing daily tablets from Sunday to Saturday, with arrows indicating the sequence. Weeks 1 to 3 have white to off-white circles, and week 4 has green circles labeled as inactive tablets.*
FDA Label Image

Label Image (Lbl530022722)

Label Image (Lbl530022722)
The image shows the Cyred EQ 0.15/0.035 mg tablet label for a 28-day pack by RPK Pharmaceuticals, Inc. It includes directions to take one tablet daily as directed, along with various manufacturing, packaging, and regulatory information. Spaces for clinic name and patient details are visible but unfilled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.